| Revenue growth | ₹907 Cr in Q2, down 2% YoY; H1 flat at ₹1,971 Cr. |
|---|---|
| Margins | Q2 EBITDA margin at 20.5%, down 297 bps on inventory costs. |
| Demand visibility | Challenging for H2 due to El Nino and soil moisture deficits. |
| Management confidence | Balanced; focused on execution through 'Good to Great' initiative amidst headwinds. |
Growth
H1 revenue fell 1% YoY; volume-led de-growth in Q2 was partly offset by early-year price hikes and specialty molecules.
Outlook
Commercial production from the ₹150 Cr Dahej herbicide intermediate plant is targeted to begin in Q2 FY28-29.
Risks
El Nino strengthening through February 2027 and 25% lower reservoir levels pose significant threats to Rabi season sowing area.
Last quarter's promises, checked
Delivered
- Guided Top Grain biostimulant launch 'in coming kharif' → launched in Q2 (= BEAT)
Partly delivered
- Guided FY26 20.7% EBITDA margin as 'sustainable' → Q2 20.5%, down 297 bps (= PARTIAL)
- Guided Dahej ₹150 Cr commercialisation in '~2 years' → reaffirmed Q2 FY28-29, not yet delivered (= PARTIAL)
Missed
- Guided continued calibrated price hikes to pass on costs → Q2 pricing 'largely stable' (= MISS)
Earnings Call Transcript filed with NSE, NSE: SUMICHEM. Summary written with AI assistance from the document.
Sumitomo Chemical India Ltd: key numbers
- Share price
- ₹335.45
- Market cap
- ₹16,744 Cr
- Revenue (annual)
- ₹3,238 Cr
- Net profit (annual)
- ₹543.0 Cr
- P/E (TTM)
- 30.0×Sector 34.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sumitomo Chemical India Ltd
All →Sumitomo Chemical India Investor Presentation: Key Takeaways
Q2FY27 revenue Rs907 Cr (-2% YoY), PAT Rs157 Cr (-11%), EBITDA margin 20.5% (-297bps). H1FY27 PAT up 5% to Rs372 Cr on revenue down 1%. Volume-led weakness; inventory cost mismatch hit margins.
Sumitomo Chemical India Q2 FY27 Results: Net Profit ₹167.4 Cr, Down 5.8% YoY
Sumitomo Chemical India Ltd reported revenue from operations of ₹907.3 Cr (-2.4% YoY) and net profit of ₹167.4 Cr (-5.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹167.4 Cr · -5.8% YoY
Sumitomo Chemical India Q2 FY27 Results: Net Profit ₹157.4 Cr, Down 11.5% YoY
Sumitomo Chemical India Ltd reported revenue from operations of ₹907.3 Cr (-2.4% YoY) and net profit of ₹157.4 Cr (-11.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹157.4 Cr · -11.5% YoY
Sumitomo Chemical India Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Listing Regulations.
Sumitomo Chemical India Board Meeting Date
Sumitomo Chemical India Limited has scheduled a board meeting for October 26, 2026, to approve the standalone and consolidated financial results for the period ended September 2026.
Sumitomo Chemical India Investor Presentation: Key Takeaways
Sumitomo Chemical reported resilient Q1FY27 results despite a difficult domestic operating environment. Revenue grew 1% to ₹1,063 cr, while Net Profit surged 20% to ₹215 cr, aided by an insurance claim.